HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 296/5/F1061    most recent 90707.2008v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Hong, N. J. Articles by Garvin, J. L. Search for Related Content PubMed PubMed Citation Articles by Hong, N. J. Articles by Garvin, J. L.

Nitric oxide reduces flow-induced superoxide production via cGMP-dependent protein kinase in thick ascending limbs

¹Division of Hypertension and Vascular Research, Henry Ford Hospital, Detroit; and ²Department of Physiology, Wayne State University, Detroit, Michigan

Submitted 25 November 2008 ; accepted in final form 21 February 2009

We have shown that increased luminal flow induces O₂^– and nitric oxide (NO) production in thick ascending limbs (TALs). However, the interaction of flow-stimulated NO and O₂^– in TALs is unclear. We hypothesized that NO inhibits flow-induced O₂^– production in TALs via cGMP-dependent protein kinase (PKG). We measured flow-stimulated O₂^– production in rat TALs using dihydroethidium in the absence and presence of L-arginine (0.3 mM), the substrate for NO synthase. The addition of L-arginine reduced flow-induced net O₂^– production from 68 ± 9 to 17 ± 4 AU/s (P < 0.002). The addition of the NO synthase inhibitor N^G-nitro-L-arginine methyl ester (L-NAME; 5 mM) in the presence of L-arginine stimulated production (L-arginine: 15 ± 4 AU/s vs. L-arginine + L-NAME: 63 ± 7 AU/s; P < 0.002). The guanylate cyclase inhibitor LY-83583 (10 µM) also enhanced flow-induced net O₂^– production in the presence of L-arginine (L-arginine: 7 ± 4 AU/s vs. L-arginine + LY-83583: 53 ± 7 AU/s; P < 0.01). In the presence of LY-83583, L-arginine only reduced flow-induced net O₂^– by 36% (LY-83583: 80 ± 7 AU/s vs. LY-83583 + L-arginine: 51 ± 3 AU/s; P < 0.006). The cGMP analog dibutyryl (db)-cGMP reduced flow-induced net O₂^– from 39 ± 9 to 7 ± 3 AU/s (P < 0.03). The PKG inhibitor KT-5823 (5 µM) partially restored flow-induced net O₂^– in the presence of L-arginine (L-arginine: 4 ± 4 AU/s vs. L-arginine + KT-5823: 32 ± 9 AU/s; P < 0.03) and db-cGMP (db-cGMP: 9 ± 7 AU/s vs. db-cGMP + KT-5823: 54 ± 5 AU/s; P < 0.01). Phosphodiesterase II inhibition had no effect on arginine-inhibited O₂^– production. We conclude that 1) NO reduces flow-stimulated O₂^– production, 2) this occurs primarily via the cGMP/PKG pathway, and 3) O₂^– scavenging by NO plays a minor role.

reactive oxygen species; soluble guanylate cyclase; phosphodiesterase; scavenging